CDXS vs PEAK
Codexis Inc (CDXS) versus PEAK (PEAK) — a side-by-side from cached financials, not a winner call.
Codexis Inc (CDXS) is a biotechnology company listed on US.
PEAK (PEAK) common stock.
Latest reported CDXS revenue for 2026-06-30 was $30.2M. Net income was -$20.7M. Revenue was up 97.8% from 2026-03-31 to 2026-06-30. CDXS currently screens at market cap $257.6M.
PEAK does not have a complete income-statement cache yet.
CDXS currently screens at market cap $257.6M.
Not investment advice. Open the CDXS and PEAK stock pages for the full models.
Not investment advice.